Trial intelligence / Profile preview

GnRH agonist luteal support in frozen embryo transfer cycles

IRCT20250714066484N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
May 2026
Countries
1
01

Overview

Phase 3, randomised, open-label trial of gonadotropin-releasing hormone agonist in female infertility (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Clinical pregnancy rate, Live birth rate and 5 more. Started May 2026; status: completed.

02

Drugs

gonadotropin-releasing hormone agonist
03

Conditions

female infertility

Beyond the preview

Go deeper on IRCT20250714066484N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250714066484N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call